Literature DB >> 3859494

Non-suppression of cortisol secretion by long term treatment with ketoconazole in patients with acute leukaemia.

P Dandona, J Mohiuddin, H G Prentice.   

Abstract

Ketoconazole, a potent antifungal agent, inhibits adrenal steroidogenesis in normal subjects during short term treatment. Since this drug is used in the long term prophylaxis of fungal infections in patients with haematological malignancies, we have investigated whether such patients have evidence of adrenocortical suppression. Six patients on long term prophylaxis with ketoconazole were given tetracosactrin stimulation tests. All patients had high basal cortisol concentrations, which increased further after administration of 25 IU of tetracosactrin. It is concluded that leukaemic patients receiving long term ketoconazole treatment do not have adrenocortical suppression. They may, in fact, have hyperstimulated adrenocortical function due to stress and hypovolaemia.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3859494      PMCID: PMC499267          DOI: 10.1136/jcp.38.6.677

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  6 in total

1.  Ketoconazole.

Authors:  R Hay
Journal:  Br Med J (Clin Res Ed)       Date:  1982 Aug 28-Sep 4

2.  The pharmacokinetics of ketoconazole in severely immunocompromised patients.

Authors:  I M Hann; H G Prentice; M Keaney; R Corringham; H A Blacklock; J Fox; E Gascoigne; J Van Cutsem
Journal:  J Antimicrob Chemother       Date:  1982-12       Impact factor: 5.790

3.  Combined treatment with ketoconazole and luteinising hormone releasing hormone analogue: a novel approach to resistant progressive prostatic cancer.

Authors:  J M Allen; D J Kerle; H Ware; A Doble; G Williams; S R Bloom
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-10

4.  Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patients.

Authors:  I M Hann; H G Prentice; R Corringham; H A Blacklock; M Keaney; M Shannon; P Noone; E Gascoigne; J Fox; E Boesen; M Szawatkowski; A V Hoffbrand
Journal:  Lancet       Date:  1982-04-10       Impact factor: 79.321

5.  Ketoconazole blocks testosterone synthesis.

Authors:  A Pont; P L Williams; S Azhar; R E Reitz; C Bochra; E R Smith; D A Stevens
Journal:  Arch Intern Med       Date:  1982-11

6.  Ketoconazole blocks adrenal steroid synthesis.

Authors:  A Pont; P L Williams; D S Loose; D Feldman; R E Reitz; C Bochra; D A Stevens
Journal:  Ann Intern Med       Date:  1982-09       Impact factor: 25.391

  6 in total
  1 in total

Review 1.  Treatment of systemic fungal infections: recent progress and current problems.

Authors:  T J Walsh; A Pizzo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-08       Impact factor: 3.267

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.